688276.SS
688276.SS
CNE100005XY6
CHANGCHUN BCHT BIOTECHNOLOGY CO
Loading chart...

Company Profile

-

Related stocks

600252.SS
600252.SS • China
GUANGXI WUZHOU ZHONGHENG GROUP
2.25 CNY
1.07B USD 1Y -17.6%
000597.SZ
000597.SZ • China
NEP.
4.91 CNY
1.05B USD 1Y -10.2%
002275.SZ
002275.SZ • China
GLSJ
12.35 CNY
1.09B USD 1Y -16%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%
600129.SS
600129.SS • China
CHONGQING TAIJI IND
13.97 CNY
1.15B USD 1Y -36.3%
002550.SZ
002550.SZ • China
QIANHONG BIO-PHARMA
6.52 CNY
1.25B USD 1Y -28.4%
002390.SZ
002390.SZ • China
XINBANG PHAR.
3.01 CNY
875.5M USD 1Y -19.5%
600488.SS
600488.SS • China
TIANJIN TIANYAO PHARMACEUTICAL
6.47 CNY
1.06B USD 1Y +59%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.2% p.a.
Max Drawdown (5Y)
-85.6%
Sharpe Ratio (5Y)
-0.70
Beta Factor
0.09
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -85.6% in the extended horizon.
ende